Clinical trials: Carrier of Phenylketonuria
Carrier of Phenylketonuria, Healthy
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
The goal of this clinical trial is to advance our understanding of the cognitive and neurophysiologic sequelae associated with suboptimal phenylalanine (Phe) metabolism in heterozygous carriers of phenylketonuria (PKU).
- Trial name
- NCT07220265
- Testing
- Phenylalanine (Phe)
- Where
- United States
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- University of Missouri-Columbia